Pharmaceutical industries make use of the imaging output obtained from simple microphotograph to sophisticated images obtained through MRI, CT, PET, X-ray, and sonography. Pharmocological researchers are focusing their attention on MRI and PET scans. The application of these imaging techniques is expected to boost productive drug research and help in the assessment of the suitability of a specific drug for treatment of human diseases. Among the imaging techniques, PET occupies the place of first choice in drug research. The researchers use radiopharmaceuticals labeled with positron emitting radionuclides. By measuring the annihilation radiation using a coincidence technique, pharmacokinetics of the drug used and its effect on metabolism can be evaluated. In drug discovery, it is important to evaluate the biological effect of the drug, its comparative efficacy, its binding affinity, and its accumulation in the target organ in effective concentration. Such valuable information could be gathered by means of using PET scan.
Bioimaging techniques are regarded as the most promising advancements in the field of present day healthcare and biomedical research. This is being recognized as one of the most comprehensive achievements, which has eased the working conditions of the physicians. In the present medical scenario majority of the diseases are being diagnosed and attended using biomedical imaging techniques. This technique requires a good amount of development to understand the basic functions of the organs in the living system. The main aim of the concept of bioimaging is to provide an effective understanding of the numerous available imaging modalities like X-ray, Commuted Tomography, Emission Tomography and Magnetic Resonance Imaging. This is done by relating the basic operating principles of these techniques with that of Imaging techniques.
RI Technologies' Global Market Research Report on Bioimaging focuses on the different types and modalities of bioimaging and their application in Research and Development and Diagnostics. The study provides global market analysis for bioimaging by Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT. The study includes estimations and predictions for the total global bioimaging market. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents and Research related to Bioimaging is also provided. A global perspective is presented in Bio Imaging Market size along with regional analysis covering North America, Europe, Asia-Pacific, Latin America, and Rest of World.
For more information on this report please contactus -
Anasuya Vemuri
RI Technologies
No comments:
Post a Comment